BloggingStocks http://www.bloggingstocks.com BloggingStocks http://www.blogsmithmedia.com/http://www.bloggingstocks.com/media/feedlogo.gif BloggingStocks http://www.bloggingstocks.com en-us Copyright 2012 Weblogs, Inc. The contents of this feed are available for non-commercial use only. Blogsmith http://www.blogsmith.com/<![CDATA[Analyst Calls: AA, BA, BLK, DCTH, EBAY, NBR, SBUX, STI, TWX ...]]>http://www.bloggingstocks.com/2010/04/22/analyst-calls-aa-ba-ebay-sbux-twx/http://www.bloggingstocks.com/2010/04/22/analyst-calls-aa-ba-ebay-sbux-twx/http://www.bloggingstocks.com/2010/04/22/analyst-calls-aa-ba-ebay-sbux-twx/#commentsFiled under: , ,

Analyst Upgrades

  • Citigroup upgraded Blackrock (BLK) to hold from sell and removed the stock from its Top Picks Live list as a sell. The firm upped its target for shares to $198 from $190.
  • Jesup & Lamont upgraded Starbucks (SBUX) to buy from hold following the company's Q2 results. The firm raised its target for shares to $32 from $25.
  • CLSA upgraded Nabors Industries (NBR) to outperform from underperform. The firm said the Q1 report was in-line with their estimate and they expect U.S. land drilling to continue to improve. The firm has a $24 price target on the stock.
  • Alcoa (AA) was upgraded to neutral from underweight at HSBC.
  • Boeing (BA) was upgraded to outperform from neutral at Credit Suisse.
  • Chipotle Mexican Grill (CMG) was upgraded to buy from hold at Jefferies.

Continue reading Analyst Calls: AA, BA, BLK, DCTH, EBAY, NBR, SBUX, STI, TWX ...

Analyst Calls: AA, BA, BLK, DCTH, EBAY, NBR, SBUX, STI, TWX ... originally appeared on BloggingStocks on Thu, 22 Apr 2010 11:40:00 EST. Please see our terms for use of feeds.

Permalink | Email this | Comments]]>AAAlcoaanalyst upgradesBABLKBoeingBZHCMGCRUCYBSDCTHdowngradesDTGEBAYELNinitiationsinthenewsNBRQLTISBUXSPGStarbucksTime WarnerTWXWLLThu, 22 Apr 2010 11:40:00 EST<![CDATA[Delcath jumps 18% as its chemotherapy agent gets orphan drug status]]>http://www.bloggingstocks.com/2009/08/31/delcath-jumps-18-as-its-chemotherapy-agent-gets-orphan-drug-sta/http://www.bloggingstocks.com/2009/08/31/delcath-jumps-18-as-its-chemotherapy-agent-gets-orphan-drug-sta/http://www.bloggingstocks.com/2009/08/31/delcath-jumps-18-as-its-chemotherapy-agent-gets-orphan-drug-sta/#commentsFiled under: ,

Delcath Systems Inc. (NASDAQ: DCTH), which in pre-market trading shot up 48%, closed the trading session up 18% to close at $3.60 after the FDA granted its chemotherapy agent doxorubicin, used primarily for live cancer an orphan drug status. The Orphan Drug Act was created to encourage and promote research for therapies of rare conditions and diseases that affect less than 200,000 a year in the United States.

Continue reading Delcath jumps 18% as its chemotherapy agent gets orphan drug status

Delcath jumps 18% as its chemotherapy agent gets orphan drug status originally appeared on BloggingStocks on Mon, 31 Aug 2009 17:30:00 EST. Please see our terms for use of feeds.

Permalink | Email this | Comments]]>cancerdcthdelcathdoxorubicinhepatocellular carcinomaHepatocellularCarcinomainthenewsliver cancerLiverCancerMon, 31 Aug 2009 17:30:00 EST